Dr. Leavitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1034 N 500 W
Provo, UT 84604Phone+1 801-225-5409Fax+1 801-225-5623
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 2003 - 2006
Geisel School of Medicine at DartmouthClass of 2003
Certifications & Licensure
UT State Medical License 2007 - 2026
CA State Medical License 2005 - 2020
Publications & Presentations
PubMed
- 16 citationsA regulatory science initiative to harmonize and standardize digital pathology and machine learning processes to speed up clinical innovation to patientsHetal D. Marble, Richard Huang, Sarah N Dudgeon, Amanda Lowe, Markus D. Herrmann
Journal of Pathology Informatics. 2020-01-01 - 49 citationsTdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblast...Robert S. Ohgami, Shuchun Zhao, Jane K. Ohgami, Matthew O. Leavitt, James L. Zehnder
The American Journal of Surgical Pathology. 2012-11-01 - 34 citationsPrognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy.Juan C. Gomez-Gelvez, Mohamed E. Salama, Sherrie L. Perkins, Matthew O. Leavitt, Kedar V. Inamdar
American Journal of Clinical Pathology. 2016-04-01
Press Mentions
Lumea Recognized as Best of State Winner for Medical InnovationApril 14th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
